Global Gene Therapy in Cardiovascular Disorder Supply, Demand and Key Producers, 2023-2029
The global Gene Therapy in Cardiovascular Disorder market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report studies the global Gene Therapy in Cardiovascular Disorder demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy in Cardiovascular Disorder, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy in Cardiovascular Disorder that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy in Cardiovascular Disorder total market, 2018-2029, (USD Million)
Global Gene Therapy in Cardiovascular Disorder total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Therapy in Cardiovascular Disorder total market, key domestic companies and share, (USD Million)
Global Gene Therapy in Cardiovascular Disorder revenue by player and market share 2018-2023, (USD Million)
Global Gene Therapy in Cardiovascular Disorder total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene Therapy in Cardiovascular Disorder total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Therapy in Cardiovascular Disorder market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Renovacor, Gene Biotherapeutics, AskBio, Human Stem Cells Institute and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy in Cardiovascular Disorder market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Therapy in Cardiovascular Disorder Market, By Region:
1. How big is the global Gene Therapy in Cardiovascular Disorder market?
2. What is the demand of the global Gene Therapy in Cardiovascular Disorder market?
3. What is the year over year growth of the global Gene Therapy in Cardiovascular Disorder market?
4. What is the total value of the global Gene Therapy in Cardiovascular Disorder market?
5. Who are the major players in the global Gene Therapy in Cardiovascular Disorder market?
6. What are the growth factors driving the market demand?
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
This report studies the global Gene Therapy in Cardiovascular Disorder demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Therapy in Cardiovascular Disorder, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Therapy in Cardiovascular Disorder that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Therapy in Cardiovascular Disorder total market, 2018-2029, (USD Million)
Global Gene Therapy in Cardiovascular Disorder total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Gene Therapy in Cardiovascular Disorder total market, key domestic companies and share, (USD Million)
Global Gene Therapy in Cardiovascular Disorder revenue by player and market share 2018-2023, (USD Million)
Global Gene Therapy in Cardiovascular Disorder total market by Type, CAGR, 2018-2029, (USD Million)
Global Gene Therapy in Cardiovascular Disorder total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Gene Therapy in Cardiovascular Disorder market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Renovacor, Gene Biotherapeutics, AskBio, Human Stem Cells Institute and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gene Therapy in Cardiovascular Disorder market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Gene Therapy in Cardiovascular Disorder Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Viral Gene Therapy
- Non-viral Gene Therapy
- Heart Disease
- Vascular Disease
- Renovacor
- Gene Biotherapeutics
- AskBio
- Human Stem Cells Institute
- Novartis
1. How big is the global Gene Therapy in Cardiovascular Disorder market?
2. What is the demand of the global Gene Therapy in Cardiovascular Disorder market?
3. What is the year over year growth of the global Gene Therapy in Cardiovascular Disorder market?
4. What is the total value of the global Gene Therapy in Cardiovascular Disorder market?
5. Who are the major players in the global Gene Therapy in Cardiovascular Disorder market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gene Therapy in Cardiovascular Disorder Introduction
1.2 World Gene Therapy in Cardiovascular Disorder Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene Therapy in Cardiovascular Disorder Total Market by Region (by Headquarter Location)
1.3.1 World Gene Therapy in Cardiovascular Disorder Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.3 China Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.4 Europe Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.5 Japan Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.6 South Korea Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.7 ASEAN Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.8 India Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy in Cardiovascular Disorder Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Therapy in Cardiovascular Disorder Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.2 World Gene Therapy in Cardiovascular Disorder Consumption Value by Region
2.2.1 World Gene Therapy in Cardiovascular Disorder Consumption Value by Region (2018-2023)
2.2.2 World Gene Therapy in Cardiovascular Disorder Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.4 China Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.5 Europe Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.6 Japan Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.7 South Korea Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.8 ASEAN Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.9 India Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
3 WORLD GENE THERAPY IN CARDIOVASCULAR DISORDER COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Therapy in Cardiovascular Disorder Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Therapy in Cardiovascular Disorder Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Therapy in Cardiovascular Disorder in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene Therapy in Cardiovascular Disorder in 2022
3.3 Gene Therapy in Cardiovascular Disorder Company Evaluation Quadrant
3.4 Gene Therapy in Cardiovascular Disorder Market: Overall Company Footprint Analysis
3.4.1 Gene Therapy in Cardiovascular Disorder Market: Region Footprint
3.4.2 Gene Therapy in Cardiovascular Disorder Market: Company Product Type Footprint
3.4.3 Gene Therapy in Cardiovascular Disorder Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Therapy in Cardiovascular Disorder Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Therapy in Cardiovascular Disorder Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene Therapy in Cardiovascular Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene Therapy in Cardiovascular Disorder Consumption Value Comparison
4.2.1 United States VS China: Gene Therapy in Cardiovascular Disorder Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Therapy in Cardiovascular Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene Therapy in Cardiovascular Disorder Companies and Market Share, 2018-2023
4.3.1 United States Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023)
4.4 China Based Companies Gene Therapy in Cardiovascular Disorder Revenue and Market Share, 2018-2023
4.4.1 China Based Gene Therapy in Cardiovascular Disorder Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023)
4.5 Rest of World Based Gene Therapy in Cardiovascular Disorder Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy in Cardiovascular Disorder Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Gene Therapy
5.2.2 Non-viral Gene Therapy
5.3 Market Segment by Type
5.3.1 World Gene Therapy in Cardiovascular Disorder Market Size by Type (2018-2023)
5.3.2 World Gene Therapy in Cardiovascular Disorder Market Size by Type (2024-2029)
5.3.3 World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy in Cardiovascular Disorder Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Heart Disease
6.2.2 Vascular Disease
6.3 Market Segment by Application
6.3.1 World Gene Therapy in Cardiovascular Disorder Market Size by Application (2018-2023)
6.3.2 World Gene Therapy in Cardiovascular Disorder Market Size by Application (2024-2029)
6.3.3 World Gene Therapy in Cardiovascular Disorder Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Renovacor
7.1.1 Renovacor Details
7.1.2 Renovacor Major Business
7.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Product and Services
7.1.4 Renovacor Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Renovacor Recent Developments/Updates
7.1.6 Renovacor Competitive Strengths & Weaknesses
7.2 Gene Biotherapeutics
7.2.1 Gene Biotherapeutics Details
7.2.2 Gene Biotherapeutics Major Business
7.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product and Services
7.2.4 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gene Biotherapeutics Recent Developments/Updates
7.2.6 Gene Biotherapeutics Competitive Strengths & Weaknesses
7.3 AskBio
7.3.1 AskBio Details
7.3.2 AskBio Major Business
7.3.3 AskBio Gene Therapy in Cardiovascular Disorder Product and Services
7.3.4 AskBio Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AskBio Recent Developments/Updates
7.3.6 AskBio Competitive Strengths & Weaknesses
7.4 Human Stem Cells Institute
7.4.1 Human Stem Cells Institute Details
7.4.2 Human Stem Cells Institute Major Business
7.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product and Services
7.4.4 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Human Stem Cells Institute Recent Developments/Updates
7.4.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Gene Therapy in Cardiovascular Disorder Product and Services
7.5.4 Novartis Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy in Cardiovascular Disorder Industry Chain
8.2 Gene Therapy in Cardiovascular Disorder Upstream Analysis
8.3 Gene Therapy in Cardiovascular Disorder Midstream Analysis
8.4 Gene Therapy in Cardiovascular Disorder Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Gene Therapy in Cardiovascular Disorder Introduction
1.2 World Gene Therapy in Cardiovascular Disorder Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Gene Therapy in Cardiovascular Disorder Total Market by Region (by Headquarter Location)
1.3.1 World Gene Therapy in Cardiovascular Disorder Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.3 China Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.4 Europe Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.5 Japan Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.6 South Korea Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.7 ASEAN Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.3.8 India Gene Therapy in Cardiovascular Disorder Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Therapy in Cardiovascular Disorder Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gene Therapy in Cardiovascular Disorder Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.2 World Gene Therapy in Cardiovascular Disorder Consumption Value by Region
2.2.1 World Gene Therapy in Cardiovascular Disorder Consumption Value by Region (2018-2023)
2.2.2 World Gene Therapy in Cardiovascular Disorder Consumption Value Forecast by Region (2024-2029)
2.3 United States Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.4 China Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.5 Europe Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.6 Japan Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.7 South Korea Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.8 ASEAN Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
2.9 India Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029)
3 WORLD GENE THERAPY IN CARDIOVASCULAR DISORDER COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Therapy in Cardiovascular Disorder Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Therapy in Cardiovascular Disorder Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Therapy in Cardiovascular Disorder in 2022
3.2.3 Global Concentration Ratios (CR8) for Gene Therapy in Cardiovascular Disorder in 2022
3.3 Gene Therapy in Cardiovascular Disorder Company Evaluation Quadrant
3.4 Gene Therapy in Cardiovascular Disorder Market: Overall Company Footprint Analysis
3.4.1 Gene Therapy in Cardiovascular Disorder Market: Region Footprint
3.4.2 Gene Therapy in Cardiovascular Disorder Market: Company Product Type Footprint
3.4.3 Gene Therapy in Cardiovascular Disorder Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Therapy in Cardiovascular Disorder Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Therapy in Cardiovascular Disorder Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Gene Therapy in Cardiovascular Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Gene Therapy in Cardiovascular Disorder Consumption Value Comparison
4.2.1 United States VS China: Gene Therapy in Cardiovascular Disorder Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Gene Therapy in Cardiovascular Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Gene Therapy in Cardiovascular Disorder Companies and Market Share, 2018-2023
4.3.1 United States Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023)
4.4 China Based Companies Gene Therapy in Cardiovascular Disorder Revenue and Market Share, 2018-2023
4.4.1 China Based Gene Therapy in Cardiovascular Disorder Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023)
4.5 Rest of World Based Gene Therapy in Cardiovascular Disorder Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Therapy in Cardiovascular Disorder Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Viral Gene Therapy
5.2.2 Non-viral Gene Therapy
5.3 Market Segment by Type
5.3.1 World Gene Therapy in Cardiovascular Disorder Market Size by Type (2018-2023)
5.3.2 World Gene Therapy in Cardiovascular Disorder Market Size by Type (2024-2029)
5.3.3 World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Gene Therapy in Cardiovascular Disorder Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Heart Disease
6.2.2 Vascular Disease
6.3 Market Segment by Application
6.3.1 World Gene Therapy in Cardiovascular Disorder Market Size by Application (2018-2023)
6.3.2 World Gene Therapy in Cardiovascular Disorder Market Size by Application (2024-2029)
6.3.3 World Gene Therapy in Cardiovascular Disorder Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Renovacor
7.1.1 Renovacor Details
7.1.2 Renovacor Major Business
7.1.3 Renovacor Gene Therapy in Cardiovascular Disorder Product and Services
7.1.4 Renovacor Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Renovacor Recent Developments/Updates
7.1.6 Renovacor Competitive Strengths & Weaknesses
7.2 Gene Biotherapeutics
7.2.1 Gene Biotherapeutics Details
7.2.2 Gene Biotherapeutics Major Business
7.2.3 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product and Services
7.2.4 Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Gene Biotherapeutics Recent Developments/Updates
7.2.6 Gene Biotherapeutics Competitive Strengths & Weaknesses
7.3 AskBio
7.3.1 AskBio Details
7.3.2 AskBio Major Business
7.3.3 AskBio Gene Therapy in Cardiovascular Disorder Product and Services
7.3.4 AskBio Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AskBio Recent Developments/Updates
7.3.6 AskBio Competitive Strengths & Weaknesses
7.4 Human Stem Cells Institute
7.4.1 Human Stem Cells Institute Details
7.4.2 Human Stem Cells Institute Major Business
7.4.3 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product and Services
7.4.4 Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Human Stem Cells Institute Recent Developments/Updates
7.4.6 Human Stem Cells Institute Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Gene Therapy in Cardiovascular Disorder Product and Services
7.5.4 Novartis Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Gene Therapy in Cardiovascular Disorder Industry Chain
8.2 Gene Therapy in Cardiovascular Disorder Upstream Analysis
8.3 Gene Therapy in Cardiovascular Disorder Midstream Analysis
8.4 Gene Therapy in Cardiovascular Disorder Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Therapy in Cardiovascular Disorder Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene Therapy in Cardiovascular Disorder Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene Therapy in Cardiovascular Disorder Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Therapy in Cardiovascular Disorder Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene Therapy in Cardiovascular Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene Therapy in Cardiovascular Disorder Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene Therapy in Cardiovascular Disorder Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene Therapy in Cardiovascular Disorder Players in 2022
Table 12. World Gene Therapy in Cardiovascular Disorder Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene Therapy in Cardiovascular Disorder Company Evaluation Quadrant
Table 14. Head Office of Key Gene Therapy in Cardiovascular Disorder Player
Table 15. Gene Therapy in Cardiovascular Disorder Market: Company Product Type Footprint
Table 16. Gene Therapy in Cardiovascular Disorder Market: Company Product Application Footprint
Table 17. Gene Therapy in Cardiovascular Disorder Mergers & Acquisitions Activity
Table 18. United States VS China Gene Therapy in Cardiovascular Disorder Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene Therapy in Cardiovascular Disorder Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene Therapy in Cardiovascular Disorder Revenue Market Share (2018-2023)
Table 23. China Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene Therapy in Cardiovascular Disorder Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene Therapy in Cardiovascular Disorder Revenue Market Share (2018-2023)
Table 29. World Gene Therapy in Cardiovascular Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene Therapy in Cardiovascular Disorder Market Size by Type (2018-2023) & (USD Million)
Table 31. World Gene Therapy in Cardiovascular Disorder Market Size by Type (2024-2029) & (USD Million)
Table 32. World Gene Therapy in Cardiovascular Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene Therapy in Cardiovascular Disorder Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene Therapy in Cardiovascular Disorder Market Size by Application (2024-2029) & (USD Million)
Table 35. Renovacor Basic Information, Area Served and Competitors
Table 36. Renovacor Major Business
Table 37. Renovacor Gene Therapy in Cardiovascular Disorder Product and Services
Table 38. Renovacor Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Renovacor Recent Developments/Updates
Table 40. Renovacor Competitive Strengths & Weaknesses
Table 41. Gene Biotherapeutics Basic Information, Area Served and Competitors
Table 42. Gene Biotherapeutics Major Business
Table 43. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product and Services
Table 44. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gene Biotherapeutics Recent Developments/Updates
Table 46. Gene Biotherapeutics Competitive Strengths & Weaknesses
Table 47. AskBio Basic Information, Area Served and Competitors
Table 48. AskBio Major Business
Table 49. AskBio Gene Therapy in Cardiovascular Disorder Product and Services
Table 50. AskBio Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AskBio Recent Developments/Updates
Table 52. AskBio Competitive Strengths & Weaknesses
Table 53. Human Stem Cells Institute Basic Information, Area Served and Competitors
Table 54. Human Stem Cells Institute Major Business
Table 55. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product and Services
Table 56. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Human Stem Cells Institute Recent Developments/Updates
Table 58. Novartis Basic Information, Area Served and Competitors
Table 59. Novartis Major Business
Table 60. Novartis Gene Therapy in Cardiovascular Disorder Product and Services
Table 61. Novartis Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Gene Therapy in Cardiovascular Disorder Upstream (Raw Materials)
Table 63. Gene Therapy in Cardiovascular Disorder Typical Customers
Table 1. World Gene Therapy in Cardiovascular Disorder Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Gene Therapy in Cardiovascular Disorder Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Gene Therapy in Cardiovascular Disorder Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Therapy in Cardiovascular Disorder Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Gene Therapy in Cardiovascular Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Gene Therapy in Cardiovascular Disorder Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Gene Therapy in Cardiovascular Disorder Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Gene Therapy in Cardiovascular Disorder Players in 2022
Table 12. World Gene Therapy in Cardiovascular Disorder Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Gene Therapy in Cardiovascular Disorder Company Evaluation Quadrant
Table 14. Head Office of Key Gene Therapy in Cardiovascular Disorder Player
Table 15. Gene Therapy in Cardiovascular Disorder Market: Company Product Type Footprint
Table 16. Gene Therapy in Cardiovascular Disorder Market: Company Product Application Footprint
Table 17. Gene Therapy in Cardiovascular Disorder Mergers & Acquisitions Activity
Table 18. United States VS China Gene Therapy in Cardiovascular Disorder Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Gene Therapy in Cardiovascular Disorder Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Gene Therapy in Cardiovascular Disorder Revenue Market Share (2018-2023)
Table 23. China Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Gene Therapy in Cardiovascular Disorder Revenue Market Share (2018-2023)
Table 26. Rest of World Based Gene Therapy in Cardiovascular Disorder Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Gene Therapy in Cardiovascular Disorder Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Gene Therapy in Cardiovascular Disorder Revenue Market Share (2018-2023)
Table 29. World Gene Therapy in Cardiovascular Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Gene Therapy in Cardiovascular Disorder Market Size by Type (2018-2023) & (USD Million)
Table 31. World Gene Therapy in Cardiovascular Disorder Market Size by Type (2024-2029) & (USD Million)
Table 32. World Gene Therapy in Cardiovascular Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Gene Therapy in Cardiovascular Disorder Market Size by Application (2018-2023) & (USD Million)
Table 34. World Gene Therapy in Cardiovascular Disorder Market Size by Application (2024-2029) & (USD Million)
Table 35. Renovacor Basic Information, Area Served and Competitors
Table 36. Renovacor Major Business
Table 37. Renovacor Gene Therapy in Cardiovascular Disorder Product and Services
Table 38. Renovacor Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Renovacor Recent Developments/Updates
Table 40. Renovacor Competitive Strengths & Weaknesses
Table 41. Gene Biotherapeutics Basic Information, Area Served and Competitors
Table 42. Gene Biotherapeutics Major Business
Table 43. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Product and Services
Table 44. Gene Biotherapeutics Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Gene Biotherapeutics Recent Developments/Updates
Table 46. Gene Biotherapeutics Competitive Strengths & Weaknesses
Table 47. AskBio Basic Information, Area Served and Competitors
Table 48. AskBio Major Business
Table 49. AskBio Gene Therapy in Cardiovascular Disorder Product and Services
Table 50. AskBio Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AskBio Recent Developments/Updates
Table 52. AskBio Competitive Strengths & Weaknesses
Table 53. Human Stem Cells Institute Basic Information, Area Served and Competitors
Table 54. Human Stem Cells Institute Major Business
Table 55. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Product and Services
Table 56. Human Stem Cells Institute Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Human Stem Cells Institute Recent Developments/Updates
Table 58. Novartis Basic Information, Area Served and Competitors
Table 59. Novartis Major Business
Table 60. Novartis Gene Therapy in Cardiovascular Disorder Product and Services
Table 61. Novartis Gene Therapy in Cardiovascular Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Gene Therapy in Cardiovascular Disorder Upstream (Raw Materials)
Table 63. Gene Therapy in Cardiovascular Disorder Typical Customers
LIST OF FIGURES
Figure 1. Gene Therapy in Cardiovascular Disorder Picture
Figure 2. World Gene Therapy in Cardiovascular Disorder Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Therapy in Cardiovascular Disorder Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 13. Gene Therapy in Cardiovascular Disorder Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene Therapy in Cardiovascular Disorder Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene Therapy in Cardiovascular Disorder by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy in Cardiovascular Disorder Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy in Cardiovascular Disorder Markets in 2022
Figure 27. United States VS China: Gene Therapy in Cardiovascular Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Therapy in Cardiovascular Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene Therapy in Cardiovascular Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type in 2022
Figure 31. Viral Gene Therapy
Figure 32. Non-viral Gene Therapy
Figure 33. World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2018-2029)
Figure 34. World Gene Therapy in Cardiovascular Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application in 2022
Figure 36. Heart Disease
Figure 37. Vascular Disease
Figure 38. Gene Therapy in Cardiovascular Disorder Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Gene Therapy in Cardiovascular Disorder Picture
Figure 2. World Gene Therapy in Cardiovascular Disorder Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Gene Therapy in Cardiovascular Disorder Total Market Size (2018-2029) & (USD Million)
Figure 4. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Gene Therapy in Cardiovascular Disorder Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Gene Therapy in Cardiovascular Disorder Revenue (2018-2029) & (USD Million)
Figure 13. Gene Therapy in Cardiovascular Disorder Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 16. World Gene Therapy in Cardiovascular Disorder Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 18. China Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 23. India Gene Therapy in Cardiovascular Disorder Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Gene Therapy in Cardiovascular Disorder by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Therapy in Cardiovascular Disorder Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Therapy in Cardiovascular Disorder Markets in 2022
Figure 27. United States VS China: Gene Therapy in Cardiovascular Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Gene Therapy in Cardiovascular Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Gene Therapy in Cardiovascular Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type in 2022
Figure 31. Viral Gene Therapy
Figure 32. Non-viral Gene Therapy
Figure 33. World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Type (2018-2029)
Figure 34. World Gene Therapy in Cardiovascular Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Gene Therapy in Cardiovascular Disorder Market Size Market Share by Application in 2022
Figure 36. Heart Disease
Figure 37. Vascular Disease
Figure 38. Gene Therapy in Cardiovascular Disorder Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
